ProSomnus

ProSomnusProSomnus
P

ProSomnus

Pioneer in Smart Sleep Medicine, offering non-CPAP alternatives for Obstructive Sleep Apnea.

DR 492016InactivePleasanton, United States
Rate

About

ProSomnus provides a technology-enabled, non-CPAP alternative for Obstructive Sleep Apnea (OSA) treatment using precision oral appliance therapy. Their FDA-cleared devices integrate with remote patient monitoring and data-driven diagnostics to improve adherence and patient outcomes, targeting a significant global market affected by OSA.
Frequently asked

What does ProSomnus do?

ProSomnus provides a technology-enabled, non-CPAP alternative for Obstructive Sleep Apnea (OSA) treatment using precision oral appliance therapy. Their FDA-cleared devices integrate with remote patient monitoring and data-driven diagnostics to improve adherence and patient outcomes, targeting a significant global market affected by OSA.

What is ProSomnus's revenue?

StartupHub estimates ProSomnus's annual revenue at $4.2M (range $1.8M to $17.1M, 29% confidence), based on comparable companies in the sector.

What is ProSomnus's valuation?

StartupHub estimates ProSomnus's effective valuation at $973.5M (range $744.8M to $1.5B, 54% confidence), based on comparable companies in the sector.

How much funding has ProSomnus raised?

ProSomnus has raised a total of $48M in funding. The most recent round on record is Strategic Investment.

Where is ProSomnus headquartered?

ProSomnus is headquartered in Pleasanton, United States.

When was ProSomnus founded?

ProSomnus was founded in 2016.

What industry does ProSomnus operate in?

ProSomnus operates in Medical Devices, HealthTech, Sleep Medicine.

What is ProSomnus's current status?

ProSomnus's current operating status is: Inactive.

Comments

No comments yet. Be the first to share your take.